GlaxoSmithKline's (GSK) cardiovascular medicine Coreg has reduced the mortality of congestive heart failure and changed the paradigm for ...
... Coreg — a judge has denied Dr. Reddy’s Laboratories’ motion for partial summary judgment that two claims in one of the contested patents are invalid. ...
... for the oral administration of small molecule drugs; it is the intellectual platform licensed by GlaxoSmithKline for the development of COREG CR'. ...
... for the oral administration of small molecule drugs; it is the intellectual platform licensed by GlaxoSmithKline for the development of COREG CR(TM). ...
Glaxo revenues also fell because two of its medications, Coreg for high blood pressure and antidepressant Wellbutrin, lost patent protection and now face ...
... a case study on generic antidepressants, the approval of the generic version of GSK’s drug Coreg, the introduction of Bill S.438, and the substantial ...
all 2 news articles
Bristow was cited for his contributions in the development of Coreg, a cardiovascular medication. US GREEN BUILDING COUNCIL: Elected Jim Bradburn, ...
The pharmaceutical researchers who helped discover and advance Coreg, GlaxoSmithKline's heart drug, are being honored Thursday as recipients of the ...